The incidence of stroke is on the rise for people with sickle cell disease, despite a major effort to encourage guidelines that could improve outcomes.
IN THE NEWS: Injectable GLP-1 drugs are an increasingly popular choice for people of all ages to address obesity. Although UCI Health pediatrician Dr. Dan Cooper is not surprised by the popularity of injectable GLP-1 weight loss drugs, he tells Science News Explores that he’s worried about their long-term safety…
UC Davis has become the only hospital in the Sacramento region to perform TAMBE, a minimally invasive, life-saving treatment for complex aortic aneurysms
Nearly 6,000 opioid-related overdose deaths occurred in California in 2021, many due to fentanyl, a synthetic opioid. To address the crisis, a team of researchers in the School of Medicine, or SOM, at the University of California, Riverside, plans to develop and implement a curriculum that offers education on substance…
A phase II trial for patients with traumatic brain injury (TBI) will aim to break the impasse of 30 years of failed clinical trials for TBI. The study will compare the effects of off-label drugs that have been found to be effective in animal studies.
The UC Board of Regents approved UCSF’s proposal to build a proton therapy facility as part of the redevelopment of the former Dogpatch Power Station, which will join only 45 other sites nationwide and will be the only facility to offer the leading-edge cancer therapy between Los Angeles and Seattle.
UC San Diego Health has been honored as a top performer for Vizient’s 2024 Bernard A. Birnbaum, MD, Quality Leadership Performance Award, marking the sixth consecutive year the health system has achieved this prominent distinction. This award places UC San Diego Health among the top academic...
Health Media Contacts
Find the best contact for health-related media inquiries.
